SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3108Someone expects more value: GHENT, Belgium, 16 January 2018 - Ablynx [Euronext nigel bates-1/16/2018
3107I remember some down days into pops. Straight as it comes. JonRobohogs-1/9/2018
3106Table of Biotech Buyouts of Partners (updated for Takeda-TIG): investorshub.advfDewDiligence_on_SI-1/8/2018
3105I've always been impressed just how little unusual price movement there is anigel bates-1/8/2018
3104How can one not like ABLX has a track star as a CEO? Oops, that was a differentBiotech Jim-1/8/2018
3103I like these guys - they've played by the book, and (IMO) deserve to stay innigel bates11/8/2018
3102Only a small position, unfortunately.scaram(o)uche-12/22/2017
3101Roche munches Ignyta (RXDX). Congrats to whoever was holding this targeted thertuck-12/22/2017
3100Missing FGEN.Robohogs-9/1/2017
3099FWIW at face value [X] The sector’s most valuable unpartnered assets – up for grichardred-8/31/2017
3098Bidding war? No, I do not think so. :-) PS: I hade JUNO, that I sold in at nearMiljenko Zuanic-8/31/2017
3097I haven't had a position in Kite for a while, but it's one of the heavy tuck-8/31/2017
3096At this point GILD gain more in MC than they paid for KITE. IF metric hold, theyMiljenko Zuanic-8/31/2017
3095In general, not only GILD,...and how many times they were right (buy price)? YouMiljenko Zuanic-8/29/2017
3094they have been criticized for overpaying for everything since as far back as i cmopgcw-8/29/2017
3093As a GILD SH I am glad that they did something with cash, but as you said time wMiljenko Zuanic-8/28/2017
3092Do not know perspective of the KITE pipelines, but think they overpaid for KITE.tuck-8/28/2017
3091Do not know perspective of the KITE pipelines, but think they overpaid for KITE.Miljenko Zuanic-8/28/2017
3090That was intentional misdirection, evidently. GILD was talking to KITE about a bDewDiligence_on_SI-8/28/2017
3089And yet, here we are, with Gilead munching KITE for $180 in cash, almost $12 biltuck-8/28/2017
3088Good news for RDUS! biopharmadive.comMiljenko Zuanic-7/31/2017
3087At this point RDUS is out of picture. finance.yahoo.com Clearly, disagreement Miljenko Zuanic17/17/2017
3086GILD needs spectra of I/O compounds, IDO is only one of them. Sure. Just sayingtuck-3/10/2017
3085GILD needs spectra of I/O compounds, IDO is only one of them. INCY brings palletMiljenko Zuanic-3/10/2017
3084Well, if GILD must have an IDO inhibitor, NLNK is available for a fraction of thtuck13/10/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News